Paediatric healthcare and nutrition have undergone substantial transformation through advances in preventive medicine, neonatal care, immunisation, diagnostics, digital health, and precision nutrition. Modern child health practice increasingly recognises that growth, neurodevelopment, immunity, metabolic function, and long-term disease risk are interconnected with nutritional status and the social environment. Malnutrition now encompasses undernutrition, micronutrient deficiencies, overweight, obesity, and diet-related non-communicable disease, often occurring within the same population or household. This review summarises the contemporary burden of paediatric illness and malnutrition, relevant biological mechanisms, clinical manifestations, diagnostic strategies, treatment principles, emerging therapies, and guideline-based recommendations. Particular emphasis is placed on the first 1,000 days, human milk feeding, age-appropriate complementary nutrition, management of severe acute malnutrition, obesity prevention, microbiome science, digital monitoring, and personalised interventions. Effective paediatric care requires integration of clinical assessment with family-centred counselling, community prevention, equitable access, and longitudinal follow-up.
Child health is shaped by the interaction of genetics, nutrition, infection, environment, socioeconomic conditions, and access to high-quality healthcare. Improvements in vaccination, antibiotics, neonatal medicine, oral rehydration, and public health infrastructure have reduced mortality from several infectious diseases, yet preventable disparities remain substantial. At the same time, paediatric clinicians are managing a complex nutritional landscape in which stunting, wasting, micronutrient deficiency, overweight, and obesity may coexist. This double burden of malnutrition complicates clinical decision-making and requires more comprehensive assessment than body weight alone.
Nutrition is not merely a supportive component of paediatric care. It regulates immune maturation, intestinal barrier integrity, skeletal development, brain growth, endocrine signalling, and tissue repair. Nutritional exposures during fetal life and early childhood may influence later risks of obesity, hypertension, diabetes, cardiovascular disease, and neurodevelopmental impairment. Accordingly, contemporary healthcare focuses on prevention across the life course, early identification of vulnerability, and interventions that are safe, culturally acceptable, affordable, and responsive to family circumstances.
Paediatric disease burden varies widely between and within countries. Infectious diseases, prematurity, congenital disorders, neonatal complications, and injuries remain important causes of morbidity and mortality, particularly where healthcare access is limited. In parallel, childhood overweight and obesity have increased in many regions, reflecting changes in food systems, physical activity, sleep patterns, urbanisation, and commercial exposure. Children may therefore experience insufficient dietary energy and micronutrients while also consuming diets high in sugar, sodium, saturated fat, and ultra-processed foods.
Undernutrition is associated with impaired linear growth, reduced immune competence, delayed cognitive development, and increased susceptibility to infection. Stunting may reflect chronic nutritional deprivation, recurrent illness, inflammation, or inadequate caregiving conditions. Wasting indicates acute or recent weight loss and carries a particularly high risk of complications. Iron deficiency remains a major concern because it can impair attention, learning, psychomotor development, and physical capacity even before anaemia becomes clinically obvious. Vitamin A, iodine, vitamin D, zinc, and folate deficiencies also contribute to preventable morbidity in vulnerable populations.
Overweight and obesity in childhood are associated with insulin resistance, dyslipidaemia, hypertension, obstructive sleep apnoea, fatty liver disease, orthopaedic problems, and psychosocial distress. Increasing numbers of children present with conditions previously considered predominantly adult diseases. The burden is unequally distributed, with social disadvantage, food insecurity, limited recreational space, and restricted access to preventive services contributing to risk.
Paediatric nutritional disorders develop through interactions among energy balance, inflammatory pathways, endocrine regulation, intestinal function, and developmental programming. In undernutrition, inadequate energy and protein availability leads to loss of adipose tissue, muscle catabolism, impaired organ function, and altered immune responses. The intestinal mucosa may become less effective as a barrier, increasing susceptibility to enteric infection and systemic inflammation. Recurrent infection further reduces appetite and nutrient absorption, creating a self-reinforcing cycle.
Obesity involves chronic positive energy balance, but its biology extends beyond excessive caloric intake. Adipose tissue can function as an endocrine organ, releasing inflammatory mediators and altering insulin, leptin, and adiponectin signalling. Early exposure to maternal obesity, gestational diabetes, excess postnatal weight gain, and obesogenic food environments may influence appetite regulation and metabolic programming. The gut microbiome may affect energy harvest, immune activity, and metabolite production, although clinical applications of microbiome manipulation remain under investigation.
Rapid brain growth during fetal life and early childhood makes adequate protein, essential fatty acids, iron, iodine, zinc, choline, and other nutrients particularly important. Deficiency during sensitive developmental windows may produce effects that are not completely reversible with later supplementation. Conversely, excessive intake of energy-dense foods can promote adiposity without providing sufficient micronutrients, creating a state of nutritional inadequacy despite high calorie consumption.
Important risk factors include prematurity, low birth weight, congenital heart or gastrointestinal disease, chronic lung disease, neurological impairment, malabsorption, food allergy, renal disease, endocrine disorders, and prolonged hospitalisation. Feeding difficulties, oral-motor dysfunction, sensory aversion, and developmental delay may limit dietary variety. Recurrent diarrhoea, parasitic disease, tuberculosis, and other chronic infections remain relevant in high-risk settings.
Social determinants are equally important. Household poverty, food insecurity, maternal depression, limited parental education, unsafe water, poor sanitation, displacement, and inadequate maternity protection can compromise feeding practices and follow-up. For overweight and obesity, family history, sedentary behaviour, insufficient sleep, high intake of sugar-sweetened beverages, frequent consumption of ultra-processed food, and extensive screen exposure are common contributors. Risk assessment should be non-stigmatising and should recognise that families often make dietary choices within constrained economic and environmental conditions.
Clinical assessment should include growth trajectory, dietary history, feeding behaviour, developmental progress, physical activity, sleep, medication exposure, and family context. Undernutrition may present with poor weight gain, reduced muscle mass, lethargy, recurrent infection, developmental delay, oedema, or delayed wound healing. Severe acute malnutrition can involve visible wasting, bilateral pitting oedema, hypothermia, hypoglycaemia, dehydration, electrolyte disturbance, and infection without typical inflammatory signs.
Children with micronutrient deficiency may have pallor, fatigue, pica, glossitis, bone pain, impaired night vision, neuropathy, thyroid enlargement, or poor concentration, although symptoms can be subtle. Obesity may initially be asymptomatic, but examination can reveal acanthosis nigricans, elevated blood pressure, hepatomegaly, sleep-disordered breathing, musculoskeletal pain, or psychosocial distress. Growth patterns should be interpreted using validated age- and sex-specific charts rather than isolated measurements.
Diagnosis begins with accurate measurement of weight, length or height, body mass index where appropriate, mid-upper-arm circumference, and head circumference in younger children. Measurements should be plotted on recognised growth standards and interpreted longitudinally. A declining percentile, crossing of major centile lines, or failure to gain expected weight may be more clinically significant than a single value.
Laboratory evaluation should be guided by clinical findings and risk. Possible investigations include complete blood count, ferritin with inflammatory markers, serum electrolytes, glucose, liver function, renal function, thyroid testing, vitamin concentrations, coeliac screening, and targeted tests for infection or malabsorption. In children with obesity, screening may include blood pressure assessment, fasting lipid profile, glucose or glycated haemoglobin, and evaluation for fatty liver disease according to age, severity, family history, and national guidance. Nutrition assessment should also consider food security, cultural practices, allergies, supplements, and access to safe food preparation.
Management should be individualised, family-centred, and directed at the underlying cause. Breastfeeding support, when desired and medically feasible, remains a central intervention during early infancy. Complementary foods should be introduced at developmentally appropriate stages while breastfeeding continues as recommended. Meals should provide adequate energy, protein, iron, zinc, essential fats, fruits, vegetables, and safe fluids, with attention to texture progression and responsive feeding.
Children with severe acute malnutrition require structured assessment for hypoglycaemia, hypothermia, dehydration, electrolyte imbalance, infection, and micronutrient deficiency. Therapeutic feeding may involve specialised formulas or ready-to-use therapeutic foods, with careful transition toward a varied family diet. Refeeding must be monitored in children at risk of metabolic complications. Treatment of infection, deworming where indicated, immunisation, psychosocial stimulation, and follow-up are essential parts of recovery rather than optional additions.
Management of paediatric obesity should avoid blame and focus on sustainable household changes. Interventions may include regular family meals, reduced sugar-sweetened beverages, increased fibre-rich foods, improved sleep, age-appropriate physical activity, reduced sedentary time, and behavioural support. Screening and treatment of hypertension, dyslipidaemia, insulin resistance, fatty liver disease, sleep apnoea, and mental health conditions should be integrated into care. Pharmacological treatment or metabolic surgery may be considered for selected adolescents with severe obesity and significant comorbidity within specialist multidisciplinary services.
Recent advances include improved neonatal nutritional support, human milk fortification strategies, point-of-care haemoglobin testing, digital growth monitoring, and community-based management of acute malnutrition. Research into precision nutrition aims to combine clinical phenotype, genetics, microbiome characteristics, metabolic markers, and dietary response to tailor interventions. Artificial intelligence-assisted decision support may help identify growth faltering or treatment risk, although algorithms require validation, transparency, and safeguards against inequitable performance.
Microbiome-directed therapies, including defined bacterial preparations, targeted prebiotics, and postbiotic metabolites, are being studied for malnutrition and inflammatory disease. Evidence is promising in selected settings but remains insufficient to replace established nutritional rehabilitation. Novel formulations of therapeutic foods seek to improve microbiota recovery, micronutrient delivery, acceptability, and affordability. Digital platforms can support remote counselling, adherence monitoring, and multidisciplinary collaboration, but they should complement rather than replace direct clinical assessment.
Guideline-consistent practice supports routine growth and developmental surveillance, exclusive breastfeeding for approximately the first six months when possible, timely introduction of safe and nutrient-dense complementary foods, and continued breastfeeding alongside complementary feeding according to family preference and public health recommendations. Health professionals should promote responsive feeding, avoid unnecessary restriction, counsel against sugar-sweetened beverages, and use age-appropriate physical activity and sleep guidance.
Children with growth faltering, severe wasting, oedema, developmental regression, persistent vomiting, chronic diarrhoea, feeding difficulty, or suspected micronutrient deficiency require prompt evaluation. Management should involve paediatricians, dietitians, nurses, speech and language specialists, psychologists, social workers, and community health teams when appropriate. Screening tools should support, not replace, clinical judgement. Communication should be respectful, culturally sensitive, trauma-informed, and free from weight stigma.
Health systems should strengthen maternity and primary care services, food and nutrition programmes, vaccination coverage, clean water and sanitation, school health, and social protection. Policies that improve access to nutritious foods and regulate harmful marketing to children are important population-level measures. Data collection should include equity indicators so that improvements in average outcomes do not conceal persistent disadvantage among rural, displaced, disabled, or economically marginalised children.
Advances in paediatric healthcare and nutrition increasingly depend on integrated prevention, early diagnosis, evidence-based treatment, and attention to social determinants. The coexistence of undernutrition, micronutrient deficiency, overweight, and obesity requires clinicians to assess the whole child rather than a single anthropometric measure or symptom. High-quality care combines growth surveillance, developmental support, appropriate feeding guidance, management of acute illness, and long-term risk reduction. Emerging precision, microbiome, digital, and therapeutic-food approaches may expand clinical options, but they must be evaluated for safety, effectiveness, affordability, and equity. Sustainable progress will require coordinated action among families, clinicians, communities, public health systems, educators, and policymakers across every stage of childhood.
1.
CDC Alerts on Dramatic Rise in Human Parvovirus B19
2.
Three out of ten breast cancers detected between screenings, study finds
3.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
4.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
5.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
1.
Erythropoiesis Modulation in Chronic Anemia Management
2.
The Life-Saving Powers of Anemia: How to Combat the Disease.
3.
Molecular Glue Therapy in Leukemia
4.
Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration
5.
Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation